The roles of catabolic factors in the development of osteoarthritis
- PMID: 24172137
- PMCID: PMC4123463
- DOI: 10.1089/ten.TEB.2013.0377
The roles of catabolic factors in the development of osteoarthritis
Abstract
Osteoarthritis (OA) is the most prevalent disease of articular joints characterized by joint space narrowing on X-ray, joint pain, and a loss of joint function through progressive cartilage degradation and intermittent synovial inflammation. Current in vitro models of OA are often monolayer cultured primary cells exposed to high concentrations of cytokines or chemokines, usually IL-1β or TNF-α. IL-1β could play a role in the early progression or even initiation of OA as evidenced by many of the in vitro studies. However, the inconsistent or outright lack of detectable IL-1β combined with high concentrations of the natural inhibitor IL-1Ra in the OA synovial fluid makes the idea of OA being IL-1β-driven questionable. Further, other stimulants, including IL-6 and matrix fragments, have been shown in vitro to cause many of the effects seen in OA at relevant concentrations found in the OA synovial fluid. More work with these stimulants and IL-1β-independent models needs to be done. Concurrently, research should be conducted with patients with OA as early as possible in the progression of their disease to be able to potentially identify, target, and treat the initiation of the disease.
Figures
Similar articles
-
Anticytokine therapy for osteoarthritis: evidence to date.Drugs Aging. 2010 Feb 1;27(2):95-115. doi: 10.2165/11319950-000000000-00000. Drugs Aging. 2010. PMID: 20104937
-
[Expression of interleukin-1beta and tumor necrosis factor-alpha in the synovium and synovial fluid of patients with Kashin-Beck disease and osteoarthritis].Nan Fang Yi Ke Da Xue Xue Bao. 2009 Jan;29(1):5-8. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19218098 Chinese.
-
Advanced oxidation protein products increase TNF-α and IL-1β expression in chondrocytes via NADPH oxidase 4 and accelerate cartilage degeneration in osteoarthritis progression.Redox Biol. 2020 Jan;28:101306. doi: 10.1016/j.redox.2019.101306. Epub 2019 Aug 22. Redox Biol. 2020. PMID: 31539804 Free PMC article.
-
The role of cytokines in osteoarthritis pathophysiology.Biorheology. 2002;39(1-2):237-46. Biorheology. 2002. PMID: 12082286 Review.
-
Pro-inflammatory cytokines: The link between obesity and osteoarthritis.Cytokine Growth Factor Rev. 2018 Dec;44:38-50. doi: 10.1016/j.cytogfr.2018.10.002. Epub 2018 Oct 11. Cytokine Growth Factor Rev. 2018. PMID: 30340925 Review.
Cited by
-
LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis.Nat Commun. 2020 Jul 9;11(1):3427. doi: 10.1038/s41467-020-17242-0. Nat Commun. 2020. PMID: 32647171 Free PMC article.
-
Zhuifeng tougu capsules inhibit the TLR4/MyD88/NF-κB signaling pathway and alleviate knee osteoarthritis: In vitro and in vivo experiments.Front Pharmacol. 2022 Sep 15;13:951860. doi: 10.3389/fphar.2022.951860. eCollection 2022. Front Pharmacol. 2022. PMID: 36188596 Free PMC article.
-
Ageing and Osteoarthritis Synergically Affect Human Synoviocyte Cells: An In Vitro Study on Sex Differences.J Clin Med. 2022 Nov 30;11(23):7125. doi: 10.3390/jcm11237125. J Clin Med. 2022. PMID: 36498698 Free PMC article.
-
Inflammatory Response of Articular Cartilage to Femoroacetabular Impingement in the Hip.Am J Sports Med. 2020 Jun;48(7):1647-1656. doi: 10.1177/0363546520918804. Epub 2020 May 8. Am J Sports Med. 2020. PMID: 32383968 Free PMC article.
-
Anti-arthritic activity of D-carvone against complete Freund's adjuvant-induced arthritis in rats through modulation of inflammatory cytokines.Korean J Physiol Pharmacol. 2020 Nov 1;24(6):453-462. doi: 10.4196/kjpp.2020.24.6.453. Korean J Physiol Pharmacol. 2020. PMID: 33093267 Free PMC article.
References
-
- Malemud C.J., Martel-Pelletier J., and Pelletier J.P.Degradation of extracellular matrix in osteoarthritis: 4 fundamental questions. J Rheumatol 14,20, 1987 - PubMed
-
- Recommendations for the medical management of osteoarthritis of the hip and knee. 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 43,1905, 2000 - PubMed
-
- Zhang W., Moskowitz R.W., Nuki G., et al. . OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16,137, 2008 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical